Sundrug Co (TSE:9989) Total Receivables: 円29,575 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9989 Sundrug Co Ltd TSE:9989
75 GF Score
Price 円3,629.00
GF Value 円4,660.55
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Sundrug Co Total Receivables?

Sundrug Co TSE:9989 -2.08% 75 Total Receivables is 円29,575 Mil as of Jun. 2026. GuruFocus rates TSE:9989 with a GF Score™ of 75/100 and a GF Value™ of 円4,660.55 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Sundrug Co's Total Receivables for the quarter that ended in Jun. 2026 was 円29,575 Mil.

Sundrug Co Total Receivables Historical Data

* Premium members only.

The historical data trend for Sundrug Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sundrug Co Total Receivables Chart

Sundrug Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33,456.00 37,503.00 42,640.00 48,384.00 51,496.00

Sundrug Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28,643.00 27,198.00 32,894.00 51,496.00 29,575.00
TSE:9989
75GF Score
Sundrug Co Ltd TSE:9989
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sundrug Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of 円29,575 Mil mean?
Sundrug Co (TSE:9989) has a Total Receivables of 円29,575 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Sundrug Co and its competitors.
Is Sundrug Co's Total Receivables too high?
Sundrug Co's current Total Receivables is 円29,575 Mil. Overall, Sundrug Co has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Total Receivables compare to competitors?
Sundrug Co's Total Receivables of 円29,575 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Providers & Services company?
A good Total Receivables depends on the Healthcare Providers & Services industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Sundrug Co and its competitors. Sundrug Co's current Total Receivables is 円29,575 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Based on GuruFocus' analysis, Sundrug Co (TSE:9989) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,660.55, compared to a current price of 円3,629.00 — trading 22.1% below its estimated fair value. The current Total Receivables is 円29,575 Mil. Sundrug Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Sundrug Co (TSE:9989), the current Total Receivables is 円29,575 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sundrug Co (TSE:9989) Overvalued in 2026?

Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued. The current stock price of 円3,629.00 is trading 22.1% below its estimated GF Value™ of 円4,660.55. GuruFocus considers Sundrug Co to be Modestly Undervalued.

Key valuation signals for TSE:9989:

  • Total Receivables: 円29,575 Mil
  • GF Value™: 円4,660.55 vs. price of 円3,629.00 (22.1% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the TSE:9989 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sundrug Co Business Description

Address 1-38-1 Wakamatsucho, Fuchu-shi, Tokyo, JPN, 183-0005
Sundrug Co Ltd is a Japanese retail company that operates drugstores and discount stores, primarily in the Tokyo metropolitan area and surrounding regions of Japan. Its core Drug Store segment sells prescription and over-the-counter pharmaceuticals, cosmetics, toiletries, and daily necessities, while its Discount Store segment offers food products, household goods, and other everyday items. The company generates the majority of its revenue from the drugstore business. Sundrug serves individual consumers through a dense network of company-operated stores, and its revenue comes mainly from in-store retail sales, supplemented by pharmacy dispensing services at stores handling prescriptions. The company also operates private-label and exclusive-brand products alongside national brands. Founded in 1968 and headquartered in Tokyo, Sundrug has expanded through new store openings and acquisitions of regional drugstore chains, positioning itself among Japan's leading drugstore operators.
75GF Score

Get the complete analysis for TSE:9989

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,629.00
Price
円4,660.55
GF Value